EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Understanding age and sex differentials in cancer incidence and mortality: An international population‐based study

Nolwen Rodet iD, Hana Zahed iD, Murielle Colombet, Freddie Bray, Valerie McCormack iD

International Journal of Cancer · 15.04.2026 · 158 (8) · 2102-2110

DOI: 10.1002/ijc.70244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 10.11.2025. Verfasst von Nolwen Rodet und 4 weiteren Autor:innen. Beteiligte Einrichtung: International Agency for Research on Cancer, Lyon, France. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most epidemiologic analyses of male‐to‐female (M:F) ratios for cancer incidence have done so to gain aetiological understanding, focusing on age‐standardized M:F rate ratios for specific cancer sites. None have quantified the extent and timing, with respect to age, of sex differentials in the total cancer burden (all sites excluding non‐melanoma skin cancer). In the present study, using data from IARC's Cancer Incidence in Five Continents for 2013–17 ( N = 60 countries) and GLOBOCAN mortality 2022 ( N = 69), we estimated ages when the sex ratios peaked and reversed from a male to a female excess, or vice versa. Across all countries included, a common 4‐period pattern was observed. For incidence, period 1 featured an early‐life male excess up to age 21 years (region‐specific means ranged from 18– to 24), followed by a period 2 multi‐fold female excess lasting until age 59 (56–65) and peaking at a F:M of 2.4:1 (2.0–2.9) at age 41 (39–47), then period 3 with a large male excess peaking at M:F of 1.5:1 (1.2–1.6) at 73 (69–85) years. For the absolute burden alone (not rates) countries with long life expectancies experienced a 4th period of a female excess of cancers/cancer deaths at ≥85 years. These patterns were also present for mortality, but with a shorter period 2 duration. In summary, this study characterizes the four age periods of alternating sex differentials in the cancer burden, providing essential information to support sex‐appropriate allocation of cancer prevention and oncology resources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansMaleFemaleIncidenceMiddle AgedAgedAdultYoung AdultAdolescentAge FactorsSex FactorsGlobal HealthAged, 80 and over

Stichwörter der Autor:innen

cancer burdenglobal burdensex differentials

Autor:innen und Institutionen

  • International Agency for Research on Cancer, Lyon, France.

ORCID-Profile: Nolwen Rodet, Hana Zahed, Valerie McCormack

Förderung

  • World Health Organization

Zitieren

APA

Rodet, N., Zahed, H., Colombet, M., Bray, F., & McCormack, V. (2026). Understanding age and sex differentials in cancer incidence and mortality: An international population‐based study. International Journal of Cancer, 158(8), 2102-2110. https://doi.org/10.1002/ijc.70244

Vancouver

Rodet N, Zahed H, Colombet M, Bray F, McCormack V. Understanding age and sex differentials in cancer incidence and mortality: An international population‐based study. International Journal of Cancer. 2026;158(8):2102-2110. doi:10.1002/ijc.70244

BibTeX
@article{Rodet2026,
  author = {Rodet, Nolwen and Zahed, Hana and Colombet, Murielle and Bray, Freddie and McCormack, Valerie},
  title = {Understanding age and sex differentials in cancer incidence and mortality: An international population‐based study},
  journal = {International Journal of Cancer},
  year = {2026},
  volume = {158},
  number = {8},
  pages = {2102--2110},
  doi = {10.1002/ijc.70244}
}
Kostenlos starten →